Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7164 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	I
2	2	118THCONGRESS
3	3	2
4	4	DSESSION H. R. 7164
5	5	To advance population research for chronic pain.
6	6	IN THE HOUSE OF REPRESENTATIVES
7	7	JANUARY31, 2024
8	8	Ms. C
9	9	ARAVEO(for herself and Mr. NUNNof Iowa) introduced the following
10	10	bill; which was referred to the Committee on Energy and Commerce
11	11	A BILL
12	12	To advance population research for chronic pain.
13	13	Be it enacted by the Senate and House of Representa-1
14	14	tives of the United States of America in Congress assembled, 2
15	15	SECTION 1. SHORT TITLE. 3
16	16	This Act may be cited as the ‘‘Advancing Research 4
17	17	for Chronic Pain Act of 2024’’. 5
18	18	SEC. 2. NATIONAL CHRONIC PAIN INFORMATION SYSTEM. 6
19	19	Part P of title III of the Public Health Service Act 7
20	20	(42 U.S.C. 280g et seq.) is amended by adding at the end 8
21	21	the following: 9
22	22	‘‘SEC. 399V–8. CHRONIC PAIN RESEARCH. 10
23	23	‘‘(a) I
24	24	NGENERAL.—The Secretary, in consultation 11
25	25	with the Director of the Centers for Disease Control and 12
26	26	VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
27	27	kjohnson on DSK7ZCZBW3PROD with $$_JOB 2
28	28	•HR 7164 IH
29	29	Prevention, the Director of the National Institutes of 1
30	30	Health, and the heads of other agencies as the Secretary 2
31	31	determines appropriate, shall— 3
32	32	‘‘(1) utilize available Federal research data to 4
33	33	clarify the incidence and prevalence of chronic pain 5
34	34	from any source, including injuries, operations, and 6
35	35	diseases and conditions; 7
36	36	‘‘(2) identify gaps in the available research data 8
37	37	and collect deidentified population research data 9
38	38	using medical claims and survey data to fill gaps in 10
39	39	available research data, such as information con-11
40	40	cerning— 12
41	41	‘‘(A) incidence and prevalence of specific 13
42	42	pain conditions; 14
43	43	‘‘(B) demographics and other information, 15
44	44	such as age, race, ethnicity, gender, and geo-16
45	45	graphic location; 17
46	46	‘‘(C) the incidence and prevalence of 18
47	47	known chronic pain conditions, as well as of 19
48	48	diseases and conditions that include or lead to 20
49	49	pain; 21
50	50	‘‘(D) risk factors that may be associated 22
51	51	with chronic pain conditions, such as genetic 23
52	52	and environmental risk factors and other infor-24
53	53	mation, as appropriate; 25
54	54	VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
55	55	kjohnson on DSK7ZCZBW3PROD with $$_JOB 3
56	56	•HR 7164 IH
57	57	‘‘(E) diagnosis and progression markers; 1
58	58	‘‘(F) both direct and indirect costs of ill-2
59	59	ness; 3
60	60	‘‘(G) the epidemiology of the conditions; 4
61	61	‘‘(H) the detection, management, and 5
62	62	treatment of the conditions; 6
63	63	‘‘(I) the epidemiology, detection, manage-7
64	64	ment, and treatment of frequent secondary or 8
65	65	co-occurring conditions, such as depressive, anx-9
66	66	iety, and substance use disorders; 10
67	67	‘‘(J) the utilization of medical and social 11
68	68	services by patients with chronic pain condi-12
69	69	tions, including the direct health care costs of 13
70	70	pain treatment, both traditional and alternative, 14
71	71	and the indirect costs (such as missed work, 15
72	72	public and private disability, and reduction in 16
73	73	productivity); and 17
74	74	‘‘(K) the effectiveness of evidence-based 18
75	75	treatment approaches on chronic pain condi-19
76	76	tions; 20
77	77	‘‘(3) develop, in collaboration with individuals 21
78	78	and organizations with appropriate chronic pain ex-22
79	79	pertise, including patients or patient advocates, epi-23
80	80	demiologists, representatives of national voluntary 24
81	81	health associations, health information technology 25
82	82	VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
83	83	kjohnson on DSK7ZCZBW3PROD with $$_JOB 4
84	84	•HR 7164 IH
85	85	experts, clinicians, and research scientists, standard 1
86	86	definitions and approaches for population research 2
87	87	on chronic pain to efficiently promote greater com-3
88	88	parability of data; and 4
89	89	‘‘(4) disseminate, pursuant to the public 5
90	90	webpage under subsection (b), and, as appropriate, 6
91	91	to the public and to other Federal departments and 7
92	92	agencies, any findings, developed population research 8
93	93	standards, and available Federal data sources re-9
94	94	lated to chronic pain. 10
95	95	‘‘(b) D
96	96	ISSEMINATION.—The Secretary, acting 11
97	97	through the Director of the Centers for Disease Control 12
98	98	and Prevention, shall establish a public webpage, to be 13
99	99	known as the Chronic Pain Information Hub, that— 14
100	100	‘‘(1) aggregates and summarizes available Fed-15
101	101	eral data sources, indicators, and peer-reviewed re-16
102	102	search related to chronic pain; 17
103	103	‘‘(2) includes an up-to-date summary of com-18
104	104	plete, underway, and planned data collection and 19
105	105	analysis related to chronic pain that is conducted 20
106	106	and supported by the Centers for Disease Control 21
107	107	and Prevention; and 22
108	108	‘‘(3) translates research findings into clinical 23
109	109	tools and resources, recommendations for closing re-24
110	110	search gaps, and recommendations for population re-25
111	111	VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
112	112	kjohnson on DSK7ZCZBW3PROD with $$_JOB 5
113	113	•HR 7164 IH
114	114	search standards for researchers, with recommenda-1
115	115	tions updated annually to incorporate research find-2
116	116	ings from the prior year. 3
117	117	‘‘(c) C
118	118	ONFLICTS OFINTEREST.—If an individual or 4
119	119	organization that collaborates with the Secretary in car-5
120	120	rying out subsection (a) receives a payment or other trans-6
121	121	fer of value of a type described in section 7
122	122	1128G(a)(1)(A)(vi) of the Social Security Act from a man-8
123	123	ufacturer of a drug (including a biological product) or de-9
124	124	vice that would be required to be disclosed pursuant to 10
125	125	section 1128G(a)(1) of the Social Security Act, if the indi-11
126	126	vidual or organization were a covered recipient or if such 12
127	127	disclosure were required upon request of or by designation 13
128	128	on behalf of a covered recipient pursuant to such section, 14
129	129	the individual or organization shall disclose to the Sec-15
130	130	retary information regarding such payment or other trans-16
131	131	fer of value. The Secretary shall make such disclosures 17
132	132	publicly available. 18
133	133	‘‘(d) R
134	134	EPORT.—Not later than 2 years after the date 19
135	135	of the enactment of the Advancing Research for Chronic 20
136	136	Pain Act of 2024, the Secretary shall submit a report to 21
137	137	Congress concerning the implementation of this section. 22
138	138	Such report shall include information on— 23
139	139	‘‘(1) the development and maintenance of the 24
140	140	Chronic Pain Information Hub; 25
141	141	VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
142	142	kjohnson on DSK7ZCZBW3PROD with $$_JOB 6
143	143	•HR 7164 IH
144	144	‘‘(2) the information made available through 1
145	145	the Chronic Pain Information Hub; 2
146	146	‘‘(3) the data gaps identified, and planned ef-3
147	147	forts to address such gaps; 4
148	148	‘‘(4) the process established for soliciting feed-5
149	149	back from collaborators; and 6
150	150	‘‘(5) feedback received from collaborators. 7
151	151	‘‘(e) D
152	152	EFINITION.—In this section, the term ‘chronic 8
153	153	pain’ means persistent or recurrent pain lasting longer 9
154	154	than 3 months. 10
155	155	‘‘(f) A
156	156	UTHORIZATION OF APPROPRIATIONS.—To 11
157	157	carry out this section, there is authorized to be appro-12
158	158	priated such sums as may be necessary for each of fiscal 13
159	159	years 2024 through 2028.’’. 14
160	160	Æ
161	161	VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6301 E:\BILLS\H7164.IH H7164
162	162	kjohnson on DSK7ZCZBW3PROD with $$_JOB